News

Pharmabiz11m
MAIA Biotechnology receives US FDA fast track designation for ateganosine for the treatment of non-small cell lung cancer
MAIA Biotechnology receives US FDA fast track designation for ateganosine for the treatment of non-small cell lung cancer: Chicago Wednesday, July 30, 2025, 17:00 Hrs [IST] MAIA B ...
Pharmabiz20m
AI adoption surges in life sciences manufacturing as talent, risk, and quality pressures intensify
AI adoption surges in life sciences manufacturing as talent, risk, and quality pressures intensify: Our Bureau, Mumbai Wednesday, July 30, 2025, 16:50 Hrs [IST] Rockwell Automatio ...
Pharmabiz1h
Veranova appoints Thomas Rohrer as vice president of bioconjugation
Veranova appoints Thomas Rohrer as vice president of bioconjugation: Devens, Massachusetts Wednesday, July 30, 2025, 16:00 ...
Pharmabiz1h
Haleon partners with Indian Dental Association to inaugurate the first D20 International Symposium
Haleon partners with Indian Dental Association to inaugurate the first D20 International Symposium: Our Bureau, Mumbai Wednesday, July 30, 2025, 15:30 Hrs [IST] Haleon (erstwhile ...
Pharmabiz2h
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria: Warren, New Jersey Wednesday, July 30, 2025, 15:00 Hrs [IST] PTC Therapeuti ...
Pharmabiz2h
Bausch Health to acquire DURECT Corporation, strengthening commitment to developing innovative solutions for patients with liver disease
Bausch Health to acquire DURECT Corporation, strengthening commitment to developing innovative solutions for patients with liver disease: Laval, Quebec Wednesday, July 30, 2025, 1 ...
Pharmabiz3h
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...
Pharmabiz4h
Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden
Ofichem expands drug substance capabilities with acquisition of Meribel Pharma Solutions’ Uppsala site in Sweden: Ter Apel, Netherlands Wednesday, July 30, 2025, 13:00 Hrs [IST] ...
Pharmabiz5h
EMA committee recommends approval of BeOne Medicines’ Tevimbra to treat neoadjuvant/adjuvant NSCLC
EMA committee recommends approval of BeOne Medicines’ Tevimbra to treat neoadjuvant/adjuvant NSCLC: San Carlos, California Wednesday, July 30, 2025, 12:00 Hrs [IST] BeOne Medici ...
Pharmabiz5h
Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad
Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad: Our Bureau, ...
Pharmabiz6h
US FDA approves Apellis Pharma’s Empaveli as the first C3G and primary IC-MPGN treatment for patients 12 and older
US FDA approves Apellis Pharma’s Empaveli as the first C3G and primary IC-MPGN treatment for patients 12 and older: Waltham, Massachusetts Wednesday, July 30, 2025, 11:00 Hrs [I ...
Pharmabiz6h
Strides posts in Q1 FY26 revenues of Rs. 1,119.7 crore, clocks Rs. 11.4.crore in operational PAT
Strides posts in Q1 FY26 revenues of Rs. 1,119.7 crore, clocks Rs. 11.4.crore in operational PAT: Our Bureau, Bengaluru Wednesday, July 30, 2025, 10:45 Hrs [IST] Strides Pharma Sc ...